THE increased risk of diabetes
may be outweighed by the benefits
of a reduction in the risk of heart
disease when taking cholesterol
lowering statins, according to
research published in The Lancet.
The study found that patients
with at least one risk factor for
diabetes were 28% more likely to
develop diabetes when using
statins, but were still 39% less likely
to have a cardiovascular illness and
17% less likely to die over the trial
period.
In addition those patients
without diabetes risk factors saw a
52% reduction in cardiovascular
illness and no increase in diabetes
risk.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Aug 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Aug 12
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.